Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06058_nanopub.RAPA1etQoSXTlSG0QbcX-94sfMp8YX6RpjSNir84EJHW8#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06058 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06058 label "XTL-6865 [drugbank:DB06058]" assertion.
- drugbank:DB06058 seeAlso DB06058 assertion.
- drugbank:DB06058 description "XTL-6865 is a combination of two fully human monoclonal antibodies (Ab68 and Ab65) against the hepatitis C virus E2 envelope protein. It is being developed to prevent HCV re-infection following a liver transplant and for the treatment of chronic HCV disease." assertion.
- drugbank:DB06058 identifier "drugbank:DB06058" assertion.
- drugbank:DB06058 title "XTL-6865" assertion.
- drugbank:DB06058 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06058 drugbank_vocabulary:drugbank-id "DB06058" assertion.
- drugbank:DB06058 bio2rdf_vocabulary:x-identifiers.org DB06058 assertion.
- drugbank:DB06058 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06058" assertion.
- drugbank:DB06058 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06058 bio2rdf_vocabulary:identifier "DB06058" assertion.